Statistics for VitaSpring Biomedical (id:11154 VSBC)
Valuation metrics
Market cap
3.30B
Enterprise value
3.10B
Trailing P/E (ttm)
2.61K
Forward P/E
PEG ratio
-11.27
Price/Sales (ttm)
663.65
Price/Book (mrq)
2.00K
Enterprise Value/Revenue
622.24
Enterprise Value/EBITDA
2.60K
Overview
Shares outstanding
206.52M
Float
Shares short
% Held by insiders
0.59%
% Held by institutions
0.00%
Average volume (10 days)
20.00
Average volume (90 days)
Price summary
52-Week low
16.00
52-Week high
16.00
52-Week change
0.00%
Beta
1.13
50-Day moving average
16.00
200-Day moving average
16.00
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
June 29th, 2020
Financials
Fiscal yearFiscal year ends
January 31th, 2022
Most recent quarter (mrq)
October 31th, 2022
Profitability
Profit margin
18.79%
Operating margin
23.62%
Operational effectiveness
Return on assets
40.98%
Return on equity
84.16%
Income statement
Revenue (ttm)
0.02
Revenue per share (ttm)
0.02
Quarterly revenue growth (yoy)
Gross profit (ttm)
2.07M
EBITDA
1.49M
Net income to common (ttm)
935.61K
Diluted EPS (ttm)
0.01
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
24.05K
Total cash per share (mrq)
0.00
Total debt (mrq)
329.63K
Total Debt/Equity (mrq)
19.61
Current ratio (mrq)
432.80%
Book value per share (mrq)
0.01
Cash flow
Cash flow statement
-240,006.00
Levered free cash flow (LFCF)
-481,095.00